Safety of a 2-day ultrarush immunotherapy in vespid allergic patients: Focus on elevated serum tryptase

Ann Allergy Asthma Immunol. 2018 Jul;121(1):130-132. doi: 10.1016/j.anai.2018.03.021. Epub 2018 Mar 22.
No abstract available

MeSH terms

  • Anaphylaxis / diagnosis
  • Anaphylaxis / immunology
  • Anaphylaxis / pathology
  • Anaphylaxis / prevention & control*
  • Animals
  • Biomarkers / blood
  • Bites and Stings / diagnosis
  • Bites and Stings / drug therapy*
  • Bites and Stings / immunology
  • Bites and Stings / pathology
  • Drug Administration Schedule
  • Female
  • Humans
  • Hymenoptera / chemistry
  • Hymenoptera / immunology
  • Immunotherapy / methods*
  • Male
  • Mast Cells / drug effects
  • Mast Cells / immunology
  • Mast Cells / pathology
  • Mastocytosis, Systemic / diagnosis
  • Mastocytosis, Systemic / drug therapy*
  • Mastocytosis, Systemic / immunology
  • Mastocytosis, Systemic / pathology
  • Prospective Studies
  • Time Factors
  • Treatment Outcome
  • Tryptases / blood*
  • Tryptases / immunology
  • Wasp Venoms / therapeutic use*

Substances

  • Biomarkers
  • Wasp Venoms
  • Tryptases